Compare VTR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTR | GEHC |
|---|---|---|
| Founded | 1983 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Computer Software: Prepackaged Software |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 35.8B |
| IPO Year | 1998 | N/A |
| Metric | VTR | GEHC |
|---|---|---|
| Price | $85.22 | $80.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $82.31 | ★ $91.17 |
| AVG Volume (30 Days) | 3.2M | ★ 4.0M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.44% | 0.17% |
| EPS Growth | ★ 184.21 | 4.84 |
| EPS | 0.54 | ★ 4.55 |
| Revenue | $5,817,438,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $10.84 | $5.90 |
| Revenue Next Year | $7.88 | $4.52 |
| P/E Ratio | $157.85 | ★ $17.66 |
| Revenue Growth | ★ 18.99 | 4.84 |
| 52 Week Low | $60.08 | $57.65 |
| 52 Week High | $87.20 | $94.80 |
| Indicator | VTR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 77.30 | 48.24 |
| Support Level | $75.81 | $76.66 |
| Resistance Level | $87.20 | $80.59 |
| Average True Range (ATR) | 1.77 | 2.37 |
| MACD | 0.91 | -0.04 |
| Stochastic Oscillator | 83.00 | 41.44 |
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).